Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8272239 | Journal of the Neurological Sciences | 2018 | 18 Pages |
Abstract
In our cohort, sequence and dosage variants were equally represented in patients, inducing their first symptoms mainly before the age of 30. For efficient genetic testing strategy, patients with early, especially juvenile onset of PD were strong candidates for both dosage and sequence variants screening of PARK2 gene.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
M.Z. Jankovic, V. Dobricic, N. Kresojevic, V. Markovic, I. Petrovic, M. Svetel, T. Pekmezovic, I. Novakovic, V. Kostic,